Healthcare 

Guggenheim Securities provides healthcare clients with independent insight and expertise across the biopharma, medical devices, tools and diagnostics, and healthcare services sectors.

Video Highlights

The Century Project: Living a Longer and Healthier Life

Healthcare Equities Sales Specialist Whitney Wolfe interviews Head of Equities Stefano Natella to discuss insights and highlights from “The Century Project,” a series of reports assessing health factors influencing longevity and healthspan.
Focus on M&A in Healthcare

Focus on M&A in Healthcare

Healthcare Equities Sales Specialist Whitney Wolfe interviews Senior Managing Director of Healthcare Investment Banking Punit Mehta to discuss his outlook for M&A across the healthcare industry.

Watch video

Representative Transactions in Healthcare

Joint Bookrunner to Vaxcyte.
Financial Advisor to Rite Aid.
Joint Active Bookrunner to BrightSpring Health Services.
Financial Advisor to Guidehouse.
Exclusive Financial Advisor to Ensemble Health Partners.
Financial Advisor to Revolution Medicines.
Financial Advisor to CorEvitas.
Financial Advisor to Amedisys.
Joint Active Bookrunner to MoonLake Immunotherapeutics.
Financial Advisor to Lannett Company, Inc..
Exclusive Financial Advisor to Zoetis, Inc..
Financial Advisor to Pfizer.
Financial Advisor to Summit Health-CityMD.
Financial Advisor to Select Rehabilitation.
Financial Advisor to Pfizer Inc..
Financial Advisor to Coronis Health.
Financial Advisor to Linden Capital Partners.
Strategic & Financial Advisor to Ensemble Health Partners.
Financial Advisor to Arena Pharmaceuticals.
Advised Physician Partners.
Financial Advisor to Carlyle.
Financial Advisor to Medical Properties Trust.
Financial Advisor to Myriad Genetics.
Lead Financial Advisor to Jazz Pharmaceuticals.
Financial Advisor to STERIS.
Financial Advisor to Magellan Health.
Financial Advisor to Biogen.
Financial Advisor to MyoKardia.
Financial Advisor to Paragon Healthcare.
Lead Financial Advisor to Wright Medical.
Financial Advisor to Vertiflex.
Financial Advisor to Cartiva.
Sole Financial Advisor to Stryker.
Financial Advisor to Kindred Healthcare, Inc..
Sole Financial Advisor to Teleflex.
Financial Advisor to Zeltiq.
Financial Advisor to Vascular Solutions, Inc..
Sole Financial Advisor to St. Jude Medical.
Lead Financial Advisor to Thoratec Corporation.

Social Media

Guggenheim Congratulates Maze Therapeutics on its Transaction

Guggenheim Securities, LLC congratulates Maze Therapeutics on the closing of its $140 million initial public offering. Guggenheim served as joint bookrunner to Maze Therapeutics on the IPO.

Read More

Guggenheim Congratulates Metsera on its Transaction

Guggenheim Securities, LLC congratulates Metsera on the closing of its $316 million initial public offering. Guggenheim served as joint bookrunner to Metsera on the IPO.

Read More

Guggenheim Congratulates Immunome on its Transaction

Guggenheim Securities, LLC congratulates Immunome, Inc. on the closing of its $172.5 million confidentially marketed public offering. Guggenheim served as joint bookrunner to Immunome on the equity offering.

Read More

To access more information related to Healthcare at Guggenheim Securities, contact GSInfo@guggenheimpartners.com.


Important Notices and Disclosures

The information and materials provided herein (the “materials”) are provided for informational and educational purposes only and should not be considered a recommendation of any particular security, strategy or investment product, as investing advice of any kind, or as offering or providing any investment product or service, or as an offer or solicitation with respect to the purchase or sale of any investment by Guggenheim Securities, LLC or any of its affiliates (“Guggenheim”). The materials are not provided in an advisory or fiduciary capacity and may not be relied upon for or in connection with the making of investment decisions. The views expressed herein are solely those of the authors and may differ from the views of other officers, directors, employees or other representatives (as to any person or entity, its “Representatives”) of Guggenheim. The authors’ opinions are subject to change without notice. Guggenheim undertakes no obligation to provide additional information or any update to or correction of the information provided herein. Sources for the information contained herein are believed to be reliable, but the information is not guaranteed as to, and Guggenheim and its Representatives make no representation or warranty regarding, accuracy or completeness of any information contained herein or otherwise. Neither Guggenheim nor its Representatives shall be liable to any person in any way whatsoever for any losses, costs or claims for reliance on the materials. Guggenheim may have a business relationship with certain issuers mentioned herein, or may otherwise underwrite, hold a position, buy or sell as principal in the securities of any issuer mentioned. Guggenheim may have in the past provided, may currently be providing and may in the future seek to provide investment banking, financial advisory and other services to, and have other material relationships with, the issuers of securities, loans and other financial instruments referred to herein and their affiliates. With respect to any position Guggenheim may hold, Guggenheim may have interests different from or adverse to your interests. None of the materials provided may be reproduced or redistributed, in whole or in part, to any other person or published in whole or in part for any purpose absent the written consent of Guggenheim. By accessing or reviewing this website, you will be deemed to have acknowledged and agreed to the matters set forth above.

Copyright © 2023 by Guggenheim Securities, LLC, a FINRA registered broker-dealer. All rights reserved.